v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities:    
Net increase (decrease) in net assets resulting from operations $ 213,435 $ 167,638
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:    
Net unrealized (appreciation) depreciation 13,157 (13,066)
Net realized (gains) losses 5,774 (3,741)
PIK interest income (7,481) (5,035)
Accretion of original issue discount on investments (22,729) (18,639)
Accretion of original issue discount on unsecured notes payable 620 221
Amortization of deferred financing costs 5,825 3,856
Amortization of deferred offering costs 1,508 694
Deferred taxes 27 2
Purchases of investments (2,977,628) (3,020,430)
Proceeds from the sales and repayments of investments 1,208,850 800,934
Changes in operating assets and liabilities:    
(Increase) decrease in due from affiliates 0 861
(Increase) decrease in interest receivable (5,763) (20,326)
(Increase) decrease in receivables from unsettled transactions (23,457) (77,313)
(Increase) decrease in due from broker 0 (3,390)
(Increase) decrease in other assets (18,339) 23
Increase (decrease) in accounts payable, accrued expenses and other liabilities (681) (444)
Increase (decrease) in base management fee and incentive fees payable 280 9,633
Increase (decrease) in due to broker (2,630) 0
Increase (decrease) in due to affiliates (337) (4,695)
Increase (decrease) in interest payable 1,269 13,127
Increase (decrease) in payables from unsettled transactions 5,034 91,829
Increase (decrease) in director fees payable (116) 0
Net cash used in operating activities (1,603,382) (2,078,261)
Financing activities:    
Distributions paid in cash (195,521) (113,935)
Borrowings under credit facilities 1,058,400 855,000
Repayments of borrowings under credit facilities (514,500) (40,000)
Issuance of unsecured notes 0 348,236
Proceeds from issuance of common shares 1,263,149 1,343,663
Deferred financing costs paid (3,652) (14,776)
Deferred offering costs paid (1,765) (855)
Share repurchases paid (57,469) (23,888)
Net cash provided by financing activities 1,548,642 2,353,445
Effect of exchange rate changes on foreign currency 1,875 (1,209)
Net increase (decrease) in cash and cash equivalents and restricted cash (52,865) 273,975
Cash and cash equivalents and restricted cash, beginning of period 524,164 151,136
Cash and cash equivalents and restricted cash, end of period 471,299 425,111
Supplemental information:    
Cash paid for interest 117,157 56,419
Non-cash financing activities:    
Deferred financing costs incurred 0 538
Deferred offering costs incurred 390 162
Distribution payable 37,039 23,927
Reinvestment of dividends during the period 75,523 45,869
Shares repurchases accrued but not yet paid 175,010 16,736
Reconciliation to the Statements of Assets and Liabilities    
Cash and cash equivalents 423,229  
Restricted cash 48,070  
Total cash and cash equivalents and restricted cash $ 471,299 $ 425,111